Panicker, Vijay <br/><br/>
Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  May 2009 
 - 1623-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1945-7197 
<br/><br/><label>Standard No.: </label>10.1210/jc.2008-1301  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>DNA--genetics<br/>Female<br/>Genetic Variation<br/>Genotype<br/>Health Status<br/>Hormone Replacement Therapy<br/>Humans<br/>Hypothyroidism--drug therapy<br/>Iodide Peroxidase--genetics<br/>Male<br/>Polymorphism, Genetic--genetics<br/>Polymorphism, Single Nucleotide--genetics<br/>Predictive Value of Tests<br/>Psychometrics<br/>Surveys and Questionnaires<br/>Thyroid Function Tests<br/>Thyrotropin--blood<br/>Thyroxine--blood<br/>Triiodothyronine--blood<br/>Iodothyronine Deiodinase Type II